In a filing, Crinetics Pharmaceuticals Inc revealed its President & CEO Struthers Richard Scott unloaded Company’s shares for reported $2.01 million on Apr 04 ’24. In the deal valued at $49.17 per share,40,951 shares were sold. As a result of this transaction, Struthers Richard Scott now holds 237,835 shares worth roughly $10.39 million.
Then, Okey Stephanie sold 17,500 shares, generating $811,650 in total proceeds. Upon selling the shares at $46.38, the Director now owns 6,000 shares.
Before that, Knight Jeff E. sold 32,359 shares. Crinetics Pharmaceuticals Inc shares valued at $1,433,675 were divested by the Chief Operating Officer at a price of $44.31 per share. As a result of the transaction, Knight Jeff E. now holds 52,580 shares, worth roughly $2.3 million.
Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.
Price Performance Review of CRNX
On Monday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock fall -2.04% to $43.68. Over the last five days, the stock has lost -5.94%. Crinetics Pharmaceuticals Inc shares have risen nearly 22.77% since the year began. Nevertheless, the stocks have risen 164.41% over the past one year. While a 52-week high of $49.58 was reached on 04/04/24, a 52-week low of $15.71 was recorded on 01/05/24. SMA at 50 days reached $41.82, while 200 days put it at $30.81. A total of 0.54 million shares were traded, compared to the trading of 0.69 million shares in the previous session.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 43.12, which if violated will result in even more drops to 42.56. On the upside, there is a resistance level at 44.56. A further resistance level may holdings at 45.44. The Relative Strength Index (RSI) on the 14-day chart is 48.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.51%. Stochastics %K at 41.43% indicates the stock is a holding.
